Ye et al. demonstrated that TET3 demethylated the miR-30d precursor gene promoter to block TGF-β1 inducing epithelial-mesenchymal transition, thereby inhibiting ovarian cancer progression [38]. This evidence concerns the gene TET3 and ovarian cancer.